Alpha-1 Research Registry
Part of paid clinical trials in Coral Gables, Florida.
- Sponsor
- Alpha-1 Foundation
- Study ID
- NCT04157049
- Status
- Recruiting
Conditions
- Alpha 1-Antitrypsin Deficiency
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Alpha-1 Research Registry is a confidential database made up of individuals diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1) and individuals identified as Alpha-1 carriers. The Registry was established to facilitate research initiatives and promote the development of improved treatments and a cure for Alpha-1.
Key Dates
- Start date
- Jun 20, 2019
- Status verified
- Jan 2024
- Primary completion
- Jun 20, 2029
- Completion
- Jun 20, 2029
Study Design
- Enrollment
- 4,000 participants (estimated)
Arms
- Arm: Alpha-1 Diagnosed IndividualsLarger patient cohorts are needed to support the clinical trials coming in the next 3-5 years. Despite widespread invitations to the Alpha-1 community from the Alpha-1 Foundation Research Registry, it is estimated that the Alpha-1 Foundation Research Registry now contains \<40% of the identified PiZZ individuals in the US.
- Arm: Carriers of Alpha-1Larger patient cohorts are needed to support the clinical trials coming in the next 3-5 years. Despite widespread invitations to the Alpha-1 community from the Alpha-1 Foundation Research Registry, it is estimated that the Alpha-1 Foundation Research Registry now contains \<40% of the identified PiZZ individuals in the US.
Primary Outcome Measure
Establish the Alpha-1 Research Registry using REDCap [ Time Frame: 2 years ]
Central Contacts
- Alison Keaveny, MBBS1-877-228-7321
- Randel Plant1-877-228-7321
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alpha-1 Foundation | Coral Gables | Florida | 33134 | Jeanine D'Armiento, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Coral Gables, FL
By research site
Related Studies
- A Study of KB408 for the Treatment of Alpha-1 Antitrypsin DeficiencyPHASE1 · Recruiting · Krystal Biotech, Inc. · Gainesville, Florida
- A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)PHASE1/PHASE2 · Recruiting · Beam Therapeutics Inc. · Birmingham, Alabama
- PiMZ Longitudinal Cohort (PiMZ Logic)Recruiting · Columbia University · Birmingham, Alabama
- Gene Therapy for Alpha 1- Antitrypsin DeficiencyPHASE1 · Recruiting · Weill Medical College of Cornell University · New York, New York